Lagneaux et al. showed that stromal cells isolated from B-CLL patients had increased TGF-β production correlating with decreased colony-stimulating activity which was corrected by neutralizing TGF-β activity [17]. This evidence concerns the gene TGFB1 and B-cell chronic lymphocytic leukemia.